‍

About the Company

Diabetes Reversal Group (DRG) is a healthcare company focused on transforming Type 2 diabetes treatment through a patented diabetes reversal system delivered entirely through telemedicine.

The company positions its model as an alternative to traditional long-term diabetes management by helping patients eliminate diabetic medications and achieve clinical reversal outcomes.

DRG is an established and profitable platform with over 16 years of operating history, more than $35 million in revenue, over 10,000 patients served, and international expansion underway.

Its mission is to reverse Type 2 diabetes at scale while reducing the global economic burden associated with the disease.

About the Role

DRG is expanding its Healthcare Executive Advisory Board and seeking a senior executive who understands how to drive healthcare adoption across employers, health systems, and payer ecosystems.

This is a strategic advisory opportunity intended for experienced leaders who can contribute relationships, commercial insight, and enterprise healthcare expertise.

The role is not ceremonial and involves active collaboration with company leadership to support growth and scale initiatives.

Responsibilities

You will provide high-level strategic guidance on growth strategy, enterprise adoption, and market positioning.

The role includes opening and advancing relationships with employers, health systems, payers, and other strategic stakeholders.

You will advise leadership on international expansion, operating scale, and execution priorities.

You will work directly with the executive team to align clinical outcomes, economic value propositions, and commercial growth plans.

You will help shape how the company expands within a rapidly evolving healthcare market focused on value-based care and cost reduction.

Requirements

Candidates should be senior healthcare executives with experience operating at enterprise scale.

You should understand employer healthcare strategies, payer ecosystems, provider systems, or healthcare commercialization models.

Applicants should bring strong strategic instincts, executive relationships, and the ability to help accelerate market adoption.

Experience in healthcare transformation, benefits strategy, population health, telemedicine, or value-based care environments is highly valuable.

The company welcomes leaders from diverse backgrounds, including researchers and clinicians.

Benefits

This is an opportunity to advise a profitable and established healthcare platform with demonstrated clinical outcomes and global expansion plans.

Compensation includes an equity investment opportunity that is IRA and 401K eligible.

Board members may also receive quarterly dividends tied to equity ownership and company profitability.

The role offers the chance to help shape a large-scale solution to one of healthcare’s most significant chronic conditions.

‍